Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Parkinson's Disease
NCT05781711Phase 2Completed
- Sponsor
- Tanta University
- Start
- Jun 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of liquid metformin (Aspargo Labs) in Parkinson's disease (PD) (2 arms), sponsored by Tanta University. Primary endpoint: Unified Parkinson's Disease Rating Scale at 3 months. Started Jun 2023; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05781711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05781711.